Stay in front of the regulations that impact the future of your diagnostics business with G2's National Intelligence Report. Coming directly from our experts in D.C. , this practical and informative coverage gives you timely, expert knowledge of the latest regulatory changes, interpretations, and implementations.

With Federal and State regulations changing more rapidly than ever before, National Intelligence Report clarifies the implications and intersections of laws and enforcement that impact your lab.

From Stark and CPT to Medicare and congressional lobbying efforts, "NIR" leaves no stone unturned in its efforts to keep you up to date and inform your business planning and risk assessment.

This biweekly news service provides concise, independent coverage and analysis of fast-breaking lab, pathology, blood banking, imaging and diagnostic radiology policy from the Nation's Capital.

Each edition of G2's National Intelligence Report covers critical areas for diagnostic businesses including:

• Medicare payment/policy directives, reforms, and advisory boards
• Billing guidelines and coding changes
• CLIA & MQSA regulatory mandates, changes and interpretations
• Congressional actions and upcoming legislative initiatives
• Federal compliance requirements
• OIG anti-fraud initiatives
• Stark self-referral prohibitions and actions

PLUS - extended coverage of Federal and State agency regulatory changes such as FDA oversight of in-vitro diagnostics, blood banks, and radiological devices OSHA, NRC, and State safety standards.

To learn more about what G2's National Intelligence Report can do to reduce risk and improve the knowledge base of your organization, contact Jonathan Wentworth-Ping, Director, at jping@G2Intelligence.com or call 973-718-4703.